Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance

Diabetologia

Volumn 43, Issue 9, 2000, Pages 1126-1135

  Pascot, A ^a   Despres J P ^b   Lemieux, I ^a   Bergeron, J ^a   Nadeau, A ^a   Prud'homme, D ^c   Tremblay, A ^c   Lemieux, S ^c  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cardiovascular disease risk; Impaired glucose tolerance; Lipid lipoprotein; Men; Visceral obesity

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ABDOMEN; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; OBESITY; QUEBEC; REFERENCE VALUES; RISK FACTORS; SKIN; TOMOGRAPHY, X-RAY COMPUTED; VISCERA;

EID: 0033816516     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051503     Document Type: Article

References (58)

1. Postchallenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men
2. The Bedford survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics
3. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study
4. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata diabetes study
5. Glucose tolerance and mortality, including a substudy of tolbutamide treatment
6. Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: The Finnish cohorts of the Seven Countries Study
7. Impaired glucose tolerance: What are the clinical implications?
8. Intra-abdominal fat, lipid metabolism and insulin resistance in coronary artery disease
9. Glucose metabolism in identical twins discordant for obesity. The critical role of visceral fat
10. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity
11. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients
12. Asymptomatic hyperglycaemia is associated with lipid and lipoprotein changes favoring atherosclerosis
13. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study
14. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance
15. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
16. Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men independently of age
17. Association of obesity and distribution of obesity with glucose tolerance and cardiovascular risk factors in the elderly
18. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease
19. Insulin resistance and body fat distribution
20. Does hyperglycaemia really cause coronary heart disease?
21. Report of the expert committee on the diagnosis and classification of diabetes mellitus
22. Evaluation and regulation of body build and composition
23. Volume of the lung determined by helium dilution
24. The gross composition of the body
25. The Airlie (VA) consensus conference (1988) Standardization of anthropometric measurements
26. Assessment of adipose tissue distribution by computed axial tomography in obese women: Association with body density and anthropometric measurements
27. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
28. Sur un dosage rapide du cholesterol lie aux beta-lipoproteines du serum
29. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
30. Increase in plasma high density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma
31. Zur bestimmung der plasmaglukosekonzentration mit der hexokinase-glucose-6-phosphat-dehydrogenase-methode
32. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays
33. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
34. Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion
35. Abdominal obesity as important component of insulin-resistance syndrome
36. Intra-abdominal adipose tissue values associated with risk of possessing elevated blood lipids and blood pressure
37. Metabolic heterogeneity in impaired glucose tolerance
38. Report of the expert committee on the diagnosis and classification of diabetes mellitus
39. Impaired glucose tolerance, Why is it not a disease?
40. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance
41. Impaired glucose tolerance, insulin resistance and cardiovascular disease
42. Mortality in noninsulin-dependent diabetes
43. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
44. Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study
45. Diabetes mellitus and macrovascular complications. An epidemiological perspective
46. Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh Artery Study
47. The insulin resistance-dyslipidemic syndrome of visceral obesity: Effect on patients' risk
48. Visceral obesity, insulin resistance, and related dyslipoproteinemias
49. Abdominal obesity and its metabolic complications: Implications for the risk of ischaemic heart disease
50. Obesity and regional body-fat distribution in men: Separate and joint relationships to glucose tolerance and plasma lipoproteins
51. Insulin resistance in visceral obesity
52. Contribution of visceral fat mass to the insulin resistance of aging
53. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease
54. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus
55. Prevention of non-insulin-dependent diabetes mellitus with physical activity
56. Visceral adipose tissue: A critical review of intervention strategies
57. Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without Type II diabetes
58. The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis